Nodal dissection for gastric cancer patient provides survival benefit when done by well-trained, experienced surgeons in high gastric cancer volume hospital

 

 

The survival benefit and morbidity after nodal dissection for gastric cancer remains controversial. We have conducted a prospective randomised trial to compare D1 and D3 dissection at a single institution, focusing on advanced gastric cancer.  

From Oct 1993 to August 1999, 335 patients were registered. 221 patients were eligible, 110 of whom were randomly assigned D1 surgery and 111 of whom were randomly assigned D3 surgery, both with curative intent. Three participating surgeons had done at least 25 independent D3 dissection before the start of the trial, and every procedure was verified by pathological analyses. Our short-term morbidity was higher in assigned D3 dissection (17.1%) compared with those assigned D1 (7.3%). There were no deaths in either group during the same admission or after discharge within 30 days of the operation. D3 dissection was associated with more complications, blood loss, operation time, and a longer hospital stay than was D1 dissection. 

Median follow-up for the 110 (50%) survivors was 94.5 months (range 62.9-135.1). Overall 5 year survival was significantly higher in patients assigned D3 surgery than in those assigned D1 surgery (59.5%[95% CI 50.3-68.7%] vs. 53.6% [44.2-63.0]; difference between groups 5.9% [-7.3 to 19.1], log-rank p=0.041). 215 patients who had R0 resection (ie. no microscopic evidence of residual disease) had recurrence at 5 years of 50.6% [41.1-60.2] for D1 surgery and 40.3% [30.9-49.7] for D3 surgery (difference between groups 10.3% [-3.2 to 23.7], log-rank p=0.197).  

We believe that a D3 resection for gastric cancer provides survival benefit by well-trained, experienced surgeons in high gastric cancer volume hospitals with minimal morbidity. 

 

Bibliographical reference:

Wu et al. “Randomized clinical study of morbidity after D1 and D3 surgery for gastric cancer”  Br J Surg 2004; 91:283-287.

Wu et al. “Nodal dissection for patients with gastric cancer: a randomised controlled trial.” Lancet Oncol 2006; 7:309-315. 

 

Chew-Wun Wu

Section of General Surgery, National Yang-Ming University and Taipei Veterans General Hospital, Taiwan